Excellent outcomes in children and adolescents with CNS                         +                          Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1

J. Kimble Frazer; Kevin J. Li; Paul J. Galardy; Sherrie L. Perkins; Anne Auperin; James R. Anderson; Ross Pinkerton; Allen Buxton; Thomas G. Gross; Jean Michon; Guy Leverger; Howard J. Weinstein; Lauren Harrison; Bruce Shiramizu; Mathew J. Barth; Stanton C. Goldman; Catherine Patte; Mitchell S. Cairo

doi:10.1111/bjh.15520

Excellent outcomes in children and adolescents with CNS ⁺ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1

J. Kimble Frazer, Kevin J. Li, Paul J. Galardy, Sherrie L. Perkins, Anne Auperin, James R. Anderson, Ross Pinkerton, Allen Buxton, Thomas G. Gross, Jean Michon, Guy Leverger, Howard J. Weinstein, Lauren Harrison, Bruce Shiramizu, Mathew J. Barth, Stanton C. Goldman, Catherine Patte, Mitchell S. Cairo

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

24 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	374-377
Nombre de pages	4
journal	British Journal of Haematology
Volume	185
Numéro de publication	2
Les DOIs	https://doi.org/10.1111/bjh.15520
état	Publié - 1 avr. 2019

Accès au document

10.1111/bjh.15520

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Frazer, J. K., Li, K. J., Galardy, P. J., Perkins, S. L., Auperin, A., Anderson, J. R., Pinkerton, R., Buxton, A., Gross, T. G., Michon, J., Leverger, G., Weinstein, H. J., Harrison, L., Shiramizu, B., Barth, M. J., Goldman, S. C., Patte, C., & Cairo, M. S. (2019). Excellent outcomes in children and adolescents with CNS ⁺ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1. British Journal of Haematology, 185(2), 374-377. https://doi.org/10.1111/bjh.15520

Frazer, J. Kimble ; Li, Kevin J. ; Galardy, Paul J. et al. / Excellent outcomes in children and adolescents with CNS ⁺ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy : results from FAB/LMB96 and COG ANHL01P1. Dans: British Journal of Haematology. 2019 ; Vol 185, Numéro 2. p. 374-377.

@article{d41df41f914c4a27b86e7a1a3a89ab2b,

title = "Excellent outcomes in children and adolescents with CNS + Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1",

keywords = "B cell non-Hodgkin lymphoma, Burkitt lymphoma, central nervous system, paediatric, rituximab",

author = "Frazer, {J. Kimble} and Li, {Kevin J.} and Galardy, {Paul J.} and Perkins, {Sherrie L.} and Anne Auperin and Anderson, {James R.} and Ross Pinkerton and Allen Buxton and Gross, {Thomas G.} and Jean Michon and Guy Leverger and Weinstein, {Howard J.} and Lauren Harrison and Bruce Shiramizu and Barth, {Mathew J.} and Goldman, {Stanton C.} and Catherine Patte and Cairo, {Mitchell S.}",

note = "Funding Information: Mitchell Cairo, MD is a consultant for Jazz Pharmaceuticals; Paul Galardy, MD received funding from Mission Therapeutics and has a financial interest in Abbott Laboratory. Funding Information: Division of Cancer Treatment, National Cancer Institute, and National Institutes of Health, Department of Health and Human Services (COG) (CA98543-09 and CA98413-09), NCTN Operations Center Grant ? (U10CA180886), NCTN Statistics & Data Center ? U10CA180899 The authors thank Erin Morris, RN, and Virginia Moore, RN, for their editorial assistance in preparing the manuscript, Mary Gerrard, MD, for her integral contributions to the FAB/LMB96 trial, Gilseung Park and Clay Foster, PhD, for statistical assistance, and the FAB/LMB96 DSMC members, Professors Michael Link, Alfred Reiter, David Harrington, and Robert Souhami, for overseeing that study.",

year = "2019",

month = apr,

day = "1",

doi = "10.1111/bjh.15520",

language = "English",

volume = "185",

pages = "374--377",

journal = "British Journal of Haematology",

issn = "0007-1048",

number = "2",

}

Frazer, JK, Li, KJ, Galardy, PJ, Perkins, SL, Auperin, A, Anderson, JR, Pinkerton, R, Buxton, A, Gross, TG, Michon, J, Leverger, G, Weinstein, HJ, Harrison, L, Shiramizu, B, Barth, MJ, Goldman, SC, Patte, C & Cairo, MS 2019, 'Excellent outcomes in children and adolescents with CNS ⁺ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1', British Journal of Haematology, VOL. 185, Numéro 2, p. 374-377. https://doi.org/10.1111/bjh.15520

Excellent outcomes in children and adolescents with CNS ⁺ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1. / Frazer, J. Kimble; Li, Kevin J.; Galardy, Paul J. et al.
Dans: British Journal of Haematology, Vol 185, Numéro 2, 01.04.2019, p. 374-377.

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

TY - JOUR

T1 - Excellent outcomes in children and adolescents with CNS + Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy

T2 - results from FAB/LMB96 and COG ANHL01P1

AU - Frazer, J. Kimble

AU - Li, Kevin J.

AU - Galardy, Paul J.

AU - Perkins, Sherrie L.

AU - Auperin, Anne

AU - Anderson, James R.

AU - Pinkerton, Ross

AU - Buxton, Allen

AU - Gross, Thomas G.

AU - Michon, Jean

AU - Leverger, Guy

AU - Weinstein, Howard J.

AU - Harrison, Lauren

AU - Shiramizu, Bruce

AU - Barth, Mathew J.

AU - Goldman, Stanton C.

AU - Patte, Catherine

AU - Cairo, Mitchell S.

N1 - Funding Information: Mitchell Cairo, MD is a consultant for Jazz Pharmaceuticals; Paul Galardy, MD received funding from Mission Therapeutics and has a financial interest in Abbott Laboratory. Funding Information: Division of Cancer Treatment, National Cancer Institute, and National Institutes of Health, Department of Health and Human Services (COG) (CA98543-09 and CA98413-09), NCTN Operations Center Grant ? (U10CA180886), NCTN Statistics & Data Center ? U10CA180899 The authors thank Erin Morris, RN, and Virginia Moore, RN, for their editorial assistance in preparing the manuscript, Mary Gerrard, MD, for her integral contributions to the FAB/LMB96 trial, Gilseung Park and Clay Foster, PhD, for statistical assistance, and the FAB/LMB96 DSMC members, Professors Michael Link, Alfred Reiter, David Harrington, and Robert Souhami, for overseeing that study.

PY - 2019/4/1

Y1 - 2019/4/1

KW - B cell non-Hodgkin lymphoma

KW - Burkitt lymphoma

KW - central nervous system

KW - paediatric

KW - rituximab

UR - http://www.scopus.com/inward/record.url?scp=85052845015&partnerID=8YFLogxK

U2 - 10.1111/bjh.15520

DO - 10.1111/bjh.15520

M3 - Letter

C2 - 30117142

AN - SCOPUS:85052845015

SN - 0007-1048

VL - 185

SP - 374

EP - 377

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 2

ER -

Frazer JK, Li KJ, Galardy PJ, Perkins SL, Auperin A, Anderson JR et al. Excellent outcomes in children and adolescents with CNS ⁺ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1. British Journal of Haematology. 2019 avr. 1;185(2):374-377. doi: 10.1111/bjh.15520